ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: Johnson & Johnson

After failed trials, J&J pivots to early-stage Alzheimer’s

After failed trials, J&J pivots to early-stage Alzheimer’s

February 13, 2013 7:55 am by | 0 Comments

CHICAGO (Reuters) - A little over a year ago, Dr. Husseini Manji, global head of neuroscience drug development at Johnson & Johnson, predicted that brain researchers were on the cusp ... Read more
FDA approves generic version of cancer drug Doxil

FDA approves generic version of cancer drug Doxil

February 4, 2013 2:09 pm by | 0 Comments

* FDA approves Sun Pharma Global FZE's generic Doxil* First generic version to be approved by FDA* Approval expected to relieve shortagesFeb 4 (Reuters) - U.S. health regulators have approved ... Read more
J&J metal hip failed because of toxic debris – expert at trial

J&J metal hip failed because of toxic debris – expert at trial

February 1, 2013 4:47 pm by | 0 Comments

LOS ANGELES (Reuters) - Toxicity caused by debris from a metal-on-metal hip implant meant that the device had to be removed from a 66-year-old man who is suing manufacturer Johnson ... Read more
Bad product vs. sick patient in first J&J hip implant trial in Los Angeles

Bad product vs. sick patient in first J&J hip implant trial in Los Angeles

January 25, 2013 6:22 pm by | 0 Comments

Los Angeles (Reuters) - Johnson & Johnson was aware of defects when it started selling its now-recalled metal hip implants in 2004, lawyers said on Friday during opening arguments in ... Read more
Johnson & Johnson CEO: Drugmakers want higher payments from government and private insurers

Johnson & Johnson CEO: Drugmakers want higher payments from government and private insurers

January 23, 2013 11:30 am by | 0 Comments

NEW YORK -- Pharmaceutical companies are pleased that health-care reform means more patients have insurance and will be encouraged to take their medicine to avoid costly hospitalizations.But, as Johnson & ... Read more
J&J beats forecast, but 2013 view lags expectations

J&J beats forecast, but 2013 view lags expectations

January 22, 2013 8:00 am by | 0 Comments

(Reuters) - Johnson & Johnson reported better-than-expected fourth-quarter earnings on Tuesday, but took another big special charge for its recalled artificial hips and forecast 2013 earnings below Wall Street forecasts.The ... Read more
J&J negotiating possible $2 billion implant settlement: Bloomberg

J&J negotiating possible $2 billion implant settlement: Bloomberg

January 18, 2013 3:33 pm by | 0 Comments

(Reuters) - Johnson & Johnson is negotiating a potential $2 billion settlement with patients who received its recalled artificial hip implant, Bloomberg News reported on Friday, citing five people familiar ... Read more
FDA OKs J&J med for drug-resistant tuberculosis that uses energy-producing enzyme

FDA OKs J&J med for drug-resistant tuberculosis that uses energy-producing enzyme

December 31, 2012 9:26 am by | 0 Comments

(Reuters) - U.S. health regulators have approved a new Johnson & Johnson drug for patients with tuberculosis who do not respond to other treatments, the company said.The drug is the ... Read more
Janssen R&D submits NDA for canagliflozin/metformin fixed-dose combo therapy

Janssen R&D submits NDA for canagliflozin/metformin fixed-dose combo therapy

December 12, 2012 2:05 pm by | 1 Comments

Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for a fixed-dose therapy ... Read more
FDA OKs J&J prostate cancer drug for use before chemo

FDA OKs J&J prostate cancer drug for use before chemo

December 10, 2012 5:16 pm by | 0 Comments

(Reuters) - U.S. health regulators on Monday expanded the approval of Johnson & Johnson's drug Zytiga for advanced prostate cancer to allow its use prior to treatment with chemotherapy.The widely-expected, ... Read more
Clinicals trial database including J&J, Lily, Merck will launch by year’s end

Clinicals trial database including J&J, Lily, Merck will launch by year’s end

November 15, 2012 9:30 am by | 0 Comments

Johnson & Johnson, Merck & Co Inc and Eli Lily & Co, plan to launch a one-stop database of global clinical trial sites aimed at streamlining paperwork and speeding the ... Read more
Soldiers-turned-CEOs: 5 healthcare companies with U.S. military veterans in the top seat

Soldiers-turned-CEOs: 5 healthcare companies with U.S. military veterans in the top seat

November 11, 2012 8:00 am by | 0 Comments

What do Johnson & Johnson, FedEx and Verizon Communications have in common? Aside from being Fortune 500 companies, they’re also led by former members of the U.S. military.According to a ... Read more
Johnson & Johnson rejects calls to break up

Johnson & Johnson rejects calls to break up

October 17, 2012 8:09 am by | 0 Comments

Johnson & Johnson will remain in one piece. The company dismissed a proposal floated by an analyst at Goldman Sachs to break up into smaller companies, as some of its ... Read more
Prostate cancer and Hepatitis C products boost Johnson & Johnson third quarter profit

Prostate cancer and Hepatitis C products boost Johnson & Johnson third quarter profit

October 16, 2012 8:05 am by | 0 Comments

(Reuters) - Johnson & Johnson reported better-than-expected quarterly results on Tuesday, as pharmaceutical sales rebounded with the help of newer products, including treatments for prostate cancer and hepatitis C.The company ... Read more
J&J diabetes drug seems to help reduce weight, blood glucose and blood pressure

J&J diabetes drug seems to help reduce weight, blood glucose and blood pressure

October 2, 2012 6:00 am by | 0 Comments

(Reuters) - An experimental treatment for type 2 diabetes developed by Johnson & Johnson proved effective at reducing blood sugar in patients on long-term insulin therapy and at high risk ... Read more